Who is sponsoring NCT05284435?

NCT05284435 is sponsored by Baylor College of Medicine.

What drugs are being tested in NCT05284435?

Interventions in NCT05284435: Cognitive Behavioral Therapy-Email (iCBT-E), Cognitive Behavioral Therapy-Email and Videoconferencing (iCBT-EV).

What condition does NCT05284435 study?

NCT05284435 studies Cognitive Behavioral Therapy, Autism Spectrum Disorder, Anxiety Disorder, Obsessive-Compulsive Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder, Specific Phobia.

Is NCT05284435 still recruiting?

NCT05284435 is currently completed. Last updated 19 December 2023.

Last reviewed 2023-12-19 · How we verify

NCT05284435

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD

Completed NA Last updated 19 December 2023

What this trial tests

NA trial testing Cognitive Behavioral Therapy-Email (iCBT-E) in Cognitive Behavioral Therapy in 114 participants. Completed in 17 December 2023.

Timeline

28 March 2022

Primary endpoint
21 August 2023

17 December 2023

Quick facts

Lead sponsor	Baylor College of Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	114
Start date	28 March 2022
Primary completion	21 August 2023
Estimated completion	17 December 2023
Sites	1 location across United States

Drugs / interventions tested

Cognitive Behavioral Therapy-Email (iCBT-E)
Cognitive Behavioral Therapy-Email and Videoconferencing (iCBT-EV)

Conditions studied

Cognitive Behavioral Therapy — all drugs for Cognitive Behavioral Therapy →
Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
Anxiety Disorder — all drugs for Anxiety Disorder →
Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →

Sponsor

Baylor College of Medicine

Who can join

Adults 7 to 15, any sex, with Cognitive Behavioral Therapy or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the effectiveness of two levels of therapist support for an internet-based, parent-led cognitive behavioral therapy for youth with anxiety and ASD.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Development and pilot testing of internet-delivered, family-based cognitive behavioral therapy for anxiety and obsessive-compulsive disorders in autistic youth.
Guzick AG, Schneider SC, Perozo Garcia AB, Kook M, et al · · 2023 · cited 5× · PMID 36908861 · DOI 10.1016/j.jocrd.2023.100789
Internet-based, parent-led cognitive behavioral therapy for autistic youth with anxiety-related disorders: A randomized trial comparing email vs. telehealth support.
Guzick AG, Schneider SC, Kook M, Greenberg R, et al · · 2024 · cited 4× · PMID 39368459 · DOI 10.1016/j.brat.2024.104639
Hereditary Patterns and Genetic Associations in Obsessive-Compulsive Disorder (OCD): Neuropsychiatric Insights, Genetic Influences, and Treatment Perspectives.
Dhiman A, Mehan S, Khan Z, Tiwari A, et al · · 2025 · cited 4× · PMID 39219434 · DOI 10.2174/0115665232316708240828063527

Verify or expand the search:

Other recruiting trials for Cognitive Behavioral Therapy

Currently open trials in the same condition.

NCT07232823 — Brief Culturally Adapted CBT for OCD · NA · recruiting
NCT06454695 — Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery · NA · recruiting
NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program · NA · recruiting
NCT05609916 — CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD · NA · recruiting
NCT04761328 — Fear of Recurrence and Stopping Immunotherapy · NA · recruiting

Other Baylor College of Medicine trials

Trials by the same sponsor.

NCT07513194 — GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) · Phase 1 · not yet recruiting
NCT05855824 — Toddler Biomarker of Nutrition Study · NA · not yet recruiting
NCT06738628 — Disposable Endoscope Platform in Third Space Endoscopic Procedures · not yet recruiting
NCT06834997 — Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital · Phase 2 · withdrawn
NCT07387614 — WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05284435 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor College of Medicine
Last refreshed: 19 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05284435.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing